Catalyst Wire Dossier Catalyst Wire Dossier

WATCHMAN Left Atrial Appendage System

· Boston Scientific Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for WATCHMAN Left Atrial Appendage System, covering 2015-05-15 to 2015-05-15. Get the full timeline:

Most recent: Clinical Trial Update: WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients With Atrial Fibrillation [Phase 2, Phase 3]

See pricing